Scholarly Index
Ad Vos
Riemser Pharma (Germany); 2,048 total citations; 86 total publications; best world rank #161
Riemser Pharma (Germany)
2,048Total citations
86Total publications
28H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Rabies epidemiology and control | Lifetime | 277 | DE 12 | 96.43 |
| Microbial infections and disease research | Lifetime | 841 | DE 49 | 95.42 |
| Virology and Viral Diseases | Lifetime | 916 | DE 61 | 94.17 |
| Poxvirus research and outbreaks | Lifetime | 439 | DE 29 | 92.46 |
| Virology and Viral Diseases | 2021-2025 | 161 | DE 10 | 87.69 |
| Rabies epidemiology and control | 2021-2025 | 177 | DE 6 | 87.93 |
| Poxvirus research and outbreaks | 2021-2025 | 777 | DE 21 | 68.24 |